[HTML][HTML] CCL4 induces inflammatory signalling and barrier disruption in the neurovascular endothelium
C Estevao, CE Bowers, D Luo, M Sarker… - Brain, behavior, & …, 2021 - Elsevier
Background During neuroinflammation many chemokines alter the function of the blood-brain
barrier (BBB) that regulates the entry of macromolecules and immune cells into the brain. …
barrier (BBB) that regulates the entry of macromolecules and immune cells into the brain. …
[PDF][PDF] LRG1 destabilizes tumor vessels and restricts immunotherapeutic potency
…, C Pilotti, A Dritsoula, R Jackstadt, CE Bowers… - Med, 2021 - cell.com
Background A poorly functioning tumor vasculature is pro-oncogenic and may impede the
delivery of therapeutics. Normalizing the vasculature, therefore, may be beneficial. We …
delivery of therapeutics. Normalizing the vasculature, therefore, may be beneficial. We …
A humanized antibody against LRG1 that Inhibits angiogenesis and reduces retinal vascular leakage
…, JWD Blackburn, M O'Connor, L Dowsett, CE Bowers… - BioRxiv, 2020 - biorxiv.org
Pathological angiogenesis contributes to morbidity in a number of diseases including cancer,
diabetic retinopathy and the neovascular form of age-related macular degeneration, …
diabetic retinopathy and the neovascular form of age-related macular degeneration, …
Experimental autoimmune uveitis: an intraocular inflammatory mouse model
CE Bowers, VL Calder, J Greenwood… - JoVE (Journal of …, 2022 - jove.com
Experimental Autoimmune Uveitis (EAU) is driven by immune cells responding to self-antigens.
Many features of this non-infectious, intraocular inflammatory disease model recapitulate …
Many features of this non-infectious, intraocular inflammatory disease model recapitulate …
Targeting LRG1 to normalize tumor vasculature and enhance therapeutic efficacy
J Greenwood, C Camilli, C Pilotti, CE Bowers, SE Moss - Cancer Research, 2022 - AACR
In recent years improving tumor vascular function, to render the tumour microenvironment
less permissive and to improve delivery of therapeutics, has gained traction due to a growing …
less permissive and to improve delivery of therapeutics, has gained traction due to a growing …
Exploring the use of high-dose simvastatin as therapy for oxidative stress in disease models of neuroinflammation
CE Bowers - 2021 - discovery.ucl.ac.uk
… I, Chantelle Elizabeth Bowers, confirm that the research presented throughout this thesis
is my own unless otherwise stated. Studies on EAE (experimental autoimmune …
is my own unless otherwise stated. Studies on EAE (experimental autoimmune …
CTLA-4 controls follicular helper T-cell differentiation by regulating the strength of CD28 engagement
…, L Wardzinski, C Bowers… - Proceedings of the …, 2015 - National Acad Sciences
Cytotoxic T-lymphocyte-associated antigen-4 (CTLA-4) is an essential regulator of T-cell
responses, and its absence precipitates lethal T-cell hyperactivity. However, whether CTLA-4 …
responses, and its absence precipitates lethal T-cell hyperactivity. However, whether CTLA-4 …
[HTML][HTML] Therapeutic validation of GEF-H1 using a de novo designed inhibitor in models of retinal disease
C Mills, SA Hemkemeyer, Z Alimajstorovic, C Bowers… - Cells, 2022 - mdpi.com
Inflammation and fibrosis are important components of diseases that contribute to the malfunction
of epithelia and endothelia. The Rho guanine nucleotide exchange factor (GEF) GEF-…
of epithelia and endothelia. The Rho guanine nucleotide exchange factor (GEF) GEF-…
Implementation of a disease management program in adult patients with heart failure
C Charais, M Bowers, OO Do… - Professional case …, 2020 - journals.lww.com
… Data for the readmission rate were retrieved by the facility's data management coordinator
through electronic audit and compared with the data from the prior year. Electronic medical …
through electronic audit and compared with the data from the prior year. Electronic medical …
[HTML][HTML] Cytosponge-trefoil factor 3 versus usual care to identify Barrett's oesophagus in a primary care setting: a multicentre, pragmatic, randomised controlled trial
…, B Donepudi, B Campbell, B Uszycka, B Bowers… - The Lancet, 2020 - thelancet.com
… Using an automated search of the electronic prescribing records of the remaining 109 clinics,
we identified 13 657 eligible patients who were sent an introductory letter with 14 days to …
we identified 13 657 eligible patients who were sent an introductory letter with 14 days to …